Regulatory

Senator Ron Wyden to deliver keynote at AHPA’s Hemp-CBD Virtual Congress

August 07, 2020

U.S. Senator Ron Wyden (D-OR) will deliver the keynote at the American Herbal Products Association’s second annual Hemp-CBD Supplement Virtual Congress on August 27, 2020.

FDA issues warning letters to sellers of supplements marketed as hangover cures

August 06, 2020

FDA issued warning letters to seven companies for illegally selling unapproved products labeled as dietary supplements that claim to cure, treat, mitigate, or prevent hangovers, in violation of the Federal Food, Drug, and Cosmetic Act.

Santé Laboratories first to test Texas hemp for THC compliance

August 06, 2020

This is the first time hemp has been grown, harvested, and processed on Texas soil, following the passage of House Bill 1325 into law on June 10, 2019 by Governor Greg Abbott.

Blue California files patent for ergothioneine as support for oxidative stress related conditions

August 03, 2020

Blue California (Rancho Santa Margarita, CA) has filed a patent for the therapeutic uses of ergothioneine.

Probiotic taxonomy change has widespread industry impact

July 20, 2020

A taxonomy change for the Lactobacillus genus will impact probiotic product labels, product claims, GMPs, and more.

House Committee approves fiscal bill, includes FDA budget for CBD enforcement

July 15, 2020

The bill provides a funding increase of $5 million to protect the public from cannabis-derived products that are in violation of the Federal Food, Drug, and Cosmetic Act, as well as to create a potential regulatory pathway for cannabis-derived products.